Old Web
English
Sign In
Acemap
>
authorDetail
>
Jeffrey Sklar
Jeffrey Sklar
Yale Cancer Center
Biology
Cancer research
Olaparib
Cancer
Homologous recombination
4
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical Efficacy of Olaparib in IDH1/IDH2-Mutant Mesenchymal Sarcomas
2021
Joseph Paul Eder
Deborah B. Doroshow
Khanh Do
Vicki L. Keedy
Jeffrey Sklar
Peter M. Glazer
Ranjit S. Bindra
Geoffrey I. Shapiro
Show All
Source
Cite
Save
Citations (4)
Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations).
2021
Haider Mahdi
Navid Hafez
Deborah Blythe Doroshow
Davendra Sohal
Vickie L. Keedy
Khanh T. Do
Patricia LoRusso
Juliane Jürgensmeier
Manuel Avedissian
Jeffrey Sklar
Colin Glover
Brunella Felicetti
Emma Dean
Peter G. Mortimer
Geoffrey I. Shapiro
Joseph Paul Eder
Show All
Source
Cite
Save
Citations (1)
Abstract B080: Update on the NCI-Molecular Analysis for Therapy Choice (NCI-MATCH/EAY131) precision medicine trial
2018
Molecular Cancer Therapeutics
Lyndsay Harris
Alice Chen
P. J. O'Dwyer
Keith T. Flaherty
Stanley R. Hamilton
Lisa M. McShane
Robert Gray
Shuli Li
Edith P. Mitchell
Diane Dragaud
Mickey Williams
Jeffrey Sklar
A. John Iafrate
David R. Patton
Richard F. Little
James Zweibel
Jeffrey S. Abrams
James H. Doroshow
Barbara A. Conley
Show All
Source
Cite
Save
Citations (6)
Abstract PR06: Targeted chemotherapy for Homologous Repair Defects (HRD) in molecularly profiled cancer patients
2017
Molecular Cancer Research
Joseph Paul Eder
Joseph Francis McLaughlin
Jeffrey Sklar
Zenta Walther
Karin Finberg
Alexandra Minnella
Juliane M. Juergensmeier
Show All
Source
Cite
Save
Citations (0)
1